Antonio Tito Fojo

17.9k total citations · 7 hit papers
137 papers, 13.6k citations indexed

About

Antonio Tito Fojo is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Antonio Tito Fojo has authored 137 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Oncology, 54 papers in Molecular Biology and 31 papers in Cancer Research. Recurrent topics in Antonio Tito Fojo's work include Drug Transport and Resistance Mechanisms (45 papers), Cancer therapeutics and mechanisms (23 papers) and Cancer, Hypoxia, and Metabolism (18 papers). Antonio Tito Fojo is often cited by papers focused on Drug Transport and Resistance Mechanisms (45 papers), Cancer therapeutics and mechanisms (23 papers) and Cancer, Hypoxia, and Metabolism (18 papers). Antonio Tito Fojo collaborates with scholars based in United States, Canada and France. Antonio Tito Fojo's co-authors include Michael M. Gottesman, Susan E. Bates, Ira Pastan, Robert W. Robey, Kazumitsu Ueda, Matthew D. Hall, Kristen M. Pluchino, David G. Poplack, Dennis J. Slamon and Shin‐ichi Akiyama and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Antonio Tito Fojo

134 papers receiving 13.3k citations

Hit Papers

Revisiting the role of AB... 1985 2026 1998 2012 2018 1987 1989 2009 1986 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Tito Fojo United States 48 8.4k 6.9k 2.1k 1.5k 1.3k 137 13.6k
Igor B. Roninson United States 67 10.6k 1.3× 11.1k 1.6× 1.8k 0.8× 1.4k 1.0× 1.8k 1.3× 158 18.1k
Robert W. Robey United States 62 9.2k 1.1× 7.3k 1.1× 1.3k 0.6× 1.2k 0.8× 2.3k 1.7× 159 13.8k
Marcel Kool Germany 51 5.5k 0.7× 8.2k 1.2× 1.3k 0.6× 1.7k 1.2× 2.1k 1.6× 215 14.4k
Kenneth H. Cowan United States 61 6.1k 0.7× 7.6k 1.1× 990 0.5× 1.9k 1.3× 661 0.5× 195 13.4k
George L. Scheffer Netherlands 62 10.5k 1.3× 5.3k 0.8× 2.7k 1.3× 777 0.5× 4.1k 3.0× 141 14.9k
Branimir I. Šikić United States 57 4.9k 0.6× 4.7k 0.7× 751 0.4× 985 0.7× 872 0.6× 225 9.6k
T Tsuruo Japan 49 5.6k 0.7× 5.4k 0.8× 957 0.5× 917 0.6× 1.3k 1.0× 155 9.7k
Charles Dumontet France 69 8.6k 1.0× 9.2k 1.3× 887 0.4× 1.9k 1.3× 401 0.3× 377 20.7k
Romano Danesi Italy 61 6.0k 0.7× 5.7k 0.8× 1.0k 0.5× 3.2k 2.2× 390 0.3× 441 13.6k
Liwu Fu China 53 4.9k 0.6× 5.4k 0.8× 674 0.3× 1.4k 0.9× 409 0.3× 209 9.9k

Countries citing papers authored by Antonio Tito Fojo

Since Specialization
Citations

This map shows the geographic impact of Antonio Tito Fojo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Tito Fojo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Tito Fojo more than expected).

Fields of papers citing papers by Antonio Tito Fojo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Tito Fojo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Tito Fojo. The network helps show where Antonio Tito Fojo may publish in the future.

Co-authorship network of co-authors of Antonio Tito Fojo

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Tito Fojo. A scholar is included among the top collaborators of Antonio Tito Fojo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Tito Fojo. Antonio Tito Fojo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fojo, Antonio Tito & Brian Labadie. (2024). Harvesting information from Kaplan-Meier plots: part 1—detecting censoring. The Oncologist. 29(7). 551–553. 1 indexed citations
2.
Scotto, Luigi, Agnès Basseville, Thomas Litman, et al.. (2023). Abstract LB_C03: Protein translation inhibition enforces histone deacetylase inhibitor activity resulting in synergistic pancreatic cancer cell death. Molecular Cancer Therapeutics. 22(12_Supplement). LB_C03–LB_C03. 1 indexed citations
3.
Litman, Thomas, Robert W. Robey, Andrés Aguilera, et al.. (2021). R-Loop–Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin. Molecular Cancer Research. 19(8). 1361–1374. 19 indexed citations
4.
Dromain, Clarisse, Arturo Loaiza‐Bonilla, Beloo Mirakhur, Thomas J.R. Beveridge, & Antonio Tito Fojo. (2021). Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors. The Oncologist. 26(4). e632–e638. 11 indexed citations
5.
Dercle, Laurent, Matthew Fronheiser, Lin Lü, et al.. (2020). Identification of Non–Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics. Clinical Cancer Research. 26(9). 2151–2162. 128 indexed citations
6.
Bruno, René, Dean Bottino, Dinesh P. de Alwis, et al.. (2019). Progress and Opportunities to Advance Clinical Cancer Therapeutics Using Tumor Dynamic Models. Clinical Cancer Research. 26(8). 1787–1795. 61 indexed citations
7.
Robey, Robert W., Kristen M. Pluchino, Matthew D. Hall, et al.. (2018). Revisiting the role of ABC transporters in multidrug-resistant cancer. Nature reviews. Cancer. 18(7). 452–464. 1382 indexed citations breakdown →
8.
Janssen, Ingo, Elise M. Blanchet, Karen T. Adams, et al.. (2015). Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB -Associated Metastatic Pheochromocytoma and Paraganglioma. Clinical Cancer Research. 21(17). 3888–3895. 180 indexed citations
9.
Poruchynsky, Marianne S., Edina Komlódi-Pásztor, Shana Y. Trostel, et al.. (2015). Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins. Proceedings of the National Academy of Sciences. 112(5). 1571–1576. 150 indexed citations
10.
Vogel, Jennifer, Tamara Prodanov, Baris I. Turkbey, et al.. (2014). External Beam Radiation Therapy in Treatment of Malignant Pheochromocytoma and Paraganglioma. Frontiers in Oncology. 4. 166–166. 42 indexed citations
11.
Gharwan, Helen, Julia Wilkerson, & Antonio Tito Fojo. (2014). GnrH-agonist co-treatment during chemotherapy for the preservation of ovarian function: a meta-analysis. Fertility and Sterility. 102(3). e159–e159. 2 indexed citations
12.
Komlódi-Pásztor, Edina, Dan L. Sackett, & Antonio Tito Fojo. (2012). Inhibitors Targeting Mitosis: Tales of How Great Drugs against a Promising Target Were Brought Down by a Flawed Rationale. Clinical Cancer Research. 18(1). 51–63. 173 indexed citations
13.
Stein, Wilfred D., Julia Wilkerson, Sindy T. Kim, et al.. (2012). Analyzing the Pivotal Trial That Compared Sunitinib and IFN-α in Renal Cell Carcinoma, Using a Method That Assesses Tumor Regression and Growth. Clinical Cancer Research. 18(8). 2374–2381. 55 indexed citations
14.
Jain, Meenu, Lisa Zhang, Mei He, et al.. (2012). Interleukin‐13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma. Cancer. 118(22). 5698–5708. 25 indexed citations
15.
Amiri‐Kordestani, Laleh, Agnès Basseville, Karen Kurdziel, Antonio Tito Fojo, & Susan E. Bates. (2012). Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies. Drug Resistance Updates. 15(1-2). 50–61. 176 indexed citations
16.
Asano, Takeshi, et al.. (1996). Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.. PubMed. 8(3). 101–10. 13 indexed citations
17.
Bates, Susan E., Zhiqing Zhan, Bruce Dickstein, et al.. (1994). Reversal of Multidrug Resistance. Journal of Hematotherapy. 3(3). 219–223. 12 indexed citations
18.
Brünner, Nils, et al.. (1993). Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.. PubMed. 53(2). 283–90. 116 indexed citations
19.
Burt, Richard K., Antonio Tito Fojo, & Snorri S. Thorgeirsson. (1990). Multidrug Resistance Due to P-Glycoprotein. Hospital Practice. 25(4). 67–77. 3 indexed citations
20.
Shen, Donglai, Antonio Tito Fojo, Igor B. Roninson, et al.. (1986). Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene.. Molecular and Cellular Biology. 6(11). 4039–4045. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026